Lilly’s tirzepatide claims head-to-head trial win against injectable semaglutide
Tirzepatide demonstrated superior A1C and body weight reduction in type 2 diabetes
Read More
Tag: tirzepatide
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
